AIRelated Layoffs A Stock Boost New Analysis Raises Doubts Pangaea PANL Q1 2026 Earnings Beat Revenue NA EPS 011 US Economic Recovery Faces Headwinds as Consumer Spending Dips Amid Geopolitical Tensions Berkshire Hathaways Greg Abel Breaks from Buffett Tradition with Tech and Airline Bets Core Inflation Hits 32 in March as Q1 GDP Growth Disappoints at 2 Utility Stocks With DecadesLong Dividend Histories Gain Added Value From AI Data Center Demand Standard Chartered Plans 15 Reduction in Corporate Functions Roles by 2030 Targets Higher Returns US Payrolls Jump More Than Expected but Report Flags Economic Risks SK Hynix Joins TrillionDollar Club as AI Chip Demand Surges Trump Seeks Supreme Court Intervention to Delay TikTok Ban The Rise of the MultiJob Workforce Economic Pressures Reshape Employment Stord Secures 250 Million in Funding to Integrate AI into ECommerce Logistics Operations X Owned by Elon Musk Fined A650000 by Australia for Child Protection Compliance Failures Pixel Launch Raises Privacy Questions Around Google Assistant AI Integration INGM Q1 2026 Earnings EPS Beats Street Estimates Stock Moves Higher Immunic Inc Q1 2026 Earnings WiderthanExpected Loss Amid No Revenue Stock Holds Gains ZM Q1 2026 Earnings Strong EPS Beat Amid Revenue Discrepancy Stock Dips Fulcrum Therapeutics Q1 2026 Earnings Narrowing Losses as Pipeline Advances Unity Software Q1 2026 Earnings Narrowed Loss Exceeds Expectations DFDV Q1 2026 Earnings EPS Miss Sends Stock Lower Amid Weak Performance Lear Corporation LEA Rebounds Strongly Approaches Key Resistance BitVentures Limited BVC Slips 35 as Shares Test Key Support Levels Loar Holdings LOAR Holds Steady Near Support Amid Low Volatility Trading SEI Investments SEIC Sees Modest Decline as Sector Rotation Continues Skyworks Solutions SWKS Hits New Lows as Selling Pressure Intensifies Phillies Bryce Harper Comments on Teams Decision to Part Ways with Injured Slugger Financial and Strategic Implications FWDI Q1 2026 Earnings EPS Surges Past Estimates with 004 Profit Stock Declines Cue Biopharma Shares Decline Sharply Key Support and Resistance Levels in Focus